Wehrenberg W B, Voltz D M, Cella S G, Müller E E, Gaillard R C
Department of Health Sciences, University of Wisconsin, Milwaukee 53211.
Neuroendocrinology. 1992 Oct;56(4):509-15. doi: 10.1159/000126268.
Interruption of hypothalamic growth hormone-releasing hormone (GHRH) secretion by administration of antiserum against GHRH (GHRH-ab) decreases growth hormone (GH) secretion and inhibits growth in rats. The present study was undertaken to investigate whether there is a period of accelerated or catch-up growth following a period of growth arrest induced by GHRH-ab treatment. Neonatal male and female rats were injected daily on days 1-14 of age. Animals received normal rabbit serum (NRS) or GHRH-ab subcutaneously at a dose of 5 microliters/10 g body weight. Body weight, serving as an index of somatic growth, was monitored over the next 3 months. The increase in absolute body weight and growth velocity of GHRH-ab-treated rats, regardless of gender, was lower than the increase of NRS-treated animals. Significant decreases were observed by day 13 of age in the female rats and day 17 in the male rats. The percent differences and absolute difference in weight between the two treatment groups clearly demonstrated that the GHRH-ab-treated rats did not demonstrate any period of catch-up growth. A second group of animals was treated in a similar fashion to evaluate serum GH concentrations at three months of age. Pulsatile GH secretion, as assessed by peak frequency and amplitude, was normal in all of the rats, suggesting that the failure of catch-up growth in the GHRH-ab-treated animals was not due to decreased GH secretion.(ABSTRACT TRUNCATED AT 250 WORDS)
通过给予抗生长激素释放激素(GHRH)抗血清(GHRH-ab)来阻断下丘脑生长激素释放激素(GHRH)的分泌,会降低大鼠生长激素(GH)的分泌并抑制其生长。本研究旨在调查在GHRH-ab治疗诱导的生长停滞期后,是否存在加速生长或追赶生长阶段。新生雄性和雌性大鼠在1-14日龄时每天接受注射。动物皮下注射正常兔血清(NRS)或GHRH-ab,剂量为5微升/10克体重。在接下来的3个月内监测作为体细胞生长指标的体重。无论性别如何,GHRH-ab治疗的大鼠的绝对体重增加和生长速度均低于NRS治疗的动物。在雌性大鼠中,13日龄时观察到显著下降;在雄性大鼠中,17日龄时观察到显著下降。两个治疗组之间的体重百分比差异和绝对差异清楚地表明,GHRH-ab治疗的大鼠没有表现出任何追赶生长阶段。以类似方式处理第二组动物,以评估3月龄时的血清GH浓度。通过峰值频率和幅度评估的脉冲式GH分泌在所有大鼠中均正常,这表明GHRH-ab治疗的动物未能追赶生长并非由于GH分泌减少。(摘要截短至250字)